Patient Support: Moderate to Severe Plaque Psoriasis | TREMFYA® (guselkumab) HCP

IN MODERATE TO SEVERE PLAQUE PSORIASIS

PATHWAYS FOR PATIENTS TO START AND STAY ON TREMFYA®

CLINICAL DECISION
TO START TREMFYA®
patient-doctor

Trial Dose (optional): If a trial is needed, prescriber may request a TREMFYA® trial through either the So Simple Trial Program*

or-icon

a Professional Sample. Trial program choice is at the prescriber’s discretion.

*The TREMFYA® So Simple Trial Program provides patients their first dose of TREMFYA® so they may determine with their provider if it is right for them. This trial program is open to patients who have commercial insurance, government coverage, or no insurance coverage. However, there is no guarantee of continuous accessibility after the program ends.

Ask your TREMFYA® Sales Representative for additional information and details.

PRIOR AUTHORIZATION SUPPORT FOR TREMFYA®

PROVIDERS CAN VISIT CoverMyMeds.com OR JanssenCarePathPortal.com

CoverMyMeds is a registered trademark of CoverMyMeds LLC. All rights reserved.

CoverMyMeds does not fill out any information that requires the medical judgment of the prescriber, and only the prescriber can determine whether to submit a prior authorization for a determination.

COVERAGE DETERMINATION

FOR COMMERCIALLY INSURED PATIENTS

If Prior Authorization is approved:

Janssen

Savings Program

Express Enrollment

If coverage determination is delayed >5 business days or denied: